An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes

PLoS Genetics

Volumn 12, Issue 4, 2016, Pages

  Bai, Ling ^a   Yang, Howard H ^a   Hu, Ying ^a   Shukla, Anjali ^a   Ha, Ngoc Han ^a   Doran, Anthony ^b   Faraji, Farhoud ^a   Goldberger, Natalie ^a   Lee, Maxwell P ^a   Keane, Thomas ^b   Hunter, Kent W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ROSIGLITAZONE; TAMOXIFEN; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL ADHESION MOLECULE; KRUPPEL LIKE FACTOR; NECTINS; SMALL INTERFERING RNA; ZBTB16 PROTEIN, MOUSE;

ARTICLE; BREAST CANCER; CARCINOGENESIS; CELLULAR IMMUNITY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENOME; HUMAN; LUNG METASTASIS; METASTASIS; MOUSE MODEL; NONHUMAN; OUTCOME ASSESSMENT; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; ANIMAL; BIOSYNTHESIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LUNG TUMOR; MAMMARY NEOPLASMS, ANIMAL; MOUSE; NEW ZEALAND BLACK MOUSE; PATHOLOGY; RNA INTERFERENCE; SECONDARY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED NZB; MICE, TRANSGENIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES;

EID: 84964867472     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1005989     Document Type: Article

References (48)

1. Ein-Dor L, Kela I, Getz G, Givol D, Domany E, Outcome signature genes in breast cancer: is there a unique set? Bioinformatics. 2005;21(2):171–8. 15308542
2. Chaffer CL, Weinberg RA, A perspective on cancer cell metastasis. Science. 331(6024):1559–64. Epub 2011/03/26. doi: 10.1126/science.120354321436443
3. Guy CT, Cardiff R.D., Muller W.J., Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. MCB. 1992;12:954–61. 1312220
4. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, et al. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer. 1998;77(4):640–4. Epub 1998/07/29. 9679770
5. Faraji F, Pang Y, Walker RC, Nieves Borges R, Yang L, Hunter KW, Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity. PLoS Genet. 2012;8(9):e1002926. Epub 2012/10/03. doi: 10.1371/journal.pgen.100292623028344
6. Kirby A, Kang HM, Wade CM, Cotsapas C, Kostem E, Han B, et al. Fine mapping in 94 inbred mouse strains using a high-density haplotype resource. Genetics. 2010;185(3):1081–95. Epub 2010/05/05. doi: 10.1534/genetics.110.11501420439770
7. Lancaster M, Rouse J, Hunter K, Modifiers for mammary tumor latency, progression and metastasis are present on mouse chromosomes 7, 9 and 17. Mamm Genome. 2005;16(2):120–6. 15859357
8. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, et al. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res. 2001;61(24):8866–72. 11751410
9. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106(23):9362–7. Epub 2009/05/29. doi: 10.1073/pnas.090310310619474294
10. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M, An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74. Epub 2012/09/08. doi: 10.1038/nature1124722955616
11. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, et al. The accessible chromatin landscape of the human genome. Nature. 2012;489(7414):75–82. Epub 2012/09/08. doi: 10.1038/nature1123222955617
12. Hosseini M, Goodstadt L, Hughes JR, Kowalczyk MS, de Gobbi M, Otto GW, et al. Causes and consequences of chromatin variation between inbred mice. PLoS Genet. 2013;9(6):e1003570. Epub 2013/06/21. doi: 10.1371/journal.pgen.100357023785304
13. John S, Sabo PJ, Thurman RE, Sung MH, Biddie SC, Johnson TA, et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet. 2011;43(3):264–8. Epub 2011/01/25. doi: 10.1038/ng.75921258342
14. Lowy DR, Rands E, Scolnick EM, Helper-independent transformation by unintegrated Harvey sarcoma virus DNA. J Virol. 1978;26(2):291–8. Epub 1978/05/01. 26810
15. Ostrowski MC, Richard-Foy H, Wolford RG, Berard DS, Hager GL, Glucocorticoid regulation of transcription at an amplified, episomal promoter. Mol Cell Biol. 1983;3(11):2045–57. Epub 1983/11/01. 6318079
16. Wong K, Bumpstead S, Van Der Weyden L, Reinholdt LG, Wilming LG, Adams DJ, et al. Sequencing and characterization of the FVB/NJ mouse genome. Genome Biol. 2012;13(8):R72. Epub 2012/08/25. doi: 10.1186/gb-2012-13-8-r7222916792
17. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nature biotechnology. 2010;28(5):495–501. Epub 2010/05/04. doi: 10.1038/nbt.163020436461
18. Churchill GA, Gatti DM, Munger SC, Svenson KL, The diversity outbred mouse population. Mamm Genome. 2012;23(9–10):713–8. Epub 2012/08/16. doi: 10.1007/s00335-012-9414-222892839
19. Roberts A, Pardo-Manuel de Villena F, Wang W, McMillan L, Threadgill DW, The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome. 2007;18(6–7):473–81. Epub 2007/08/04. 17674098
20. Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, et al. Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS One. 2013;8(8):e72287. Epub 2013/09/10. doi: 10.1371/journal.pone.007228724015230
21. Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J, GOBO: gene expression-based outcome for breast cancer online. PLoS One. 2011;6(3):e17911. Epub 2011/03/30. doi: 10.1371/journal.pone.001791121445301
22. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346–52. Epub 2012/04/24. doi: 10.1038/nature1098322522925
23. Singh A, Loscalzo J, Brigham and Women's Hospital. The Brigham intensive review of internal medicine. New York: Oxford University Press; 2012. p. p.
24. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007;8(5):R76. Epub 2007/05/12. 17493263
25. Pfefferle AD, Herschkowitz JI, Usary J, Harrell JC, Spike BT, Adams JR, et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013;14(11):R125. Epub 2013/11/14. doi: 10.1186/gb-2013-14-11-r12524220145
26. Hu Y, Wu G, Rusch M, Lukes L, Buetow KH, Zhang J, et al. Integrated cross-species transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci U S A. 2012;109(8):3184–9. Epub 2012/02/07. doi: 10.1073/pnas.111787210922308418
27. The International HapMap Project. Nature. 2003;426(6968):789–96. Epub 2003/12/20. 14685227
28. Geiger TR, Ha NH, Faraji F, Michael HT, Rodriguez L, Walker RC, et al. Functional analysis of prognostic gene expression network genes in metastatic breast cancer models. PLoS One. 2014;9(11):e111813. Epub 2014/11/05. doi: 10.1371/journal.pone.011181325368990
29. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133(1):66–77. Epub 2008/04/09. doi: 10.1016/j.cell.2008.01.04618394990
30. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10(2):182–6. Epub 2004/01/06. 14704791
31. Goldberg SF, Miele ME, Hatta N, Takata M, Paquette-Straub C, Freedman LP, et al. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 2003;63(2):432–40. Epub 2003/01/25. 12543799
32. Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008;68(13):5405–13. Epub 2008/07/03. doi: 10.1158/0008-5472.CAN-07-520618593943
33. Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C, An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007;8(8):R157. Epub 2007/08/09. 17683518
34. Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res. 2005;65(10):4059–66. 15899795
35. Leivonen SK, Kahari VM, Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer. 2007;121(10):2119–24. Epub 2007/09/13. 17849476
36. Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, et al. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Molecular cancer therapeutics. 2009;8(11):3117–29. Epub 2009/11/06. doi: 10.1158/1535-7163.MCT-09-044819887554
37. Essayan DM, Cyclic nucleotide phosphodiesterases. The Journal of allergy and clinical immunology. 2001;108(5):671–80. Epub 2001/11/03. 11692087
38. Yang H, Rouse J, Lukes L, Lancaster M, Veenstra T, Zhou M, et al. Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis. 2005;21(8):719–35.
39. Magenta G, Borenstein X, Rolando R, Jasnis MA, Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3. BMC Cancer. 2008;8:47. doi: 10.1186/1471-2407-8-4718261208
40. Singh A, Loscalzo J, Brigham and Women's Hospital. The Brigham intensive review of internal medicine. Second edition. ed. p. p.
41. Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW, Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res. 2006;8(2):R16. 16563182
42. Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW, Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res. 2009;11(5):R75. Epub 2009/10/15. doi: 10.1186/bcr241219825179
43. Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, et al. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer. 2009;124(7):1716–20. Epub 2008/12/18. doi: 10.1002/ijc.2391919089925
44. Kim HJ, Kwon H, Lee JW, Kim HJ, Lee SB, Park HS, et al. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes. Breast Cancer Res. 2015;17(64).
45. El-Haggar SM, El-Shitany NA, Mostafa MF, El-Bassiouny NA, Metformin may protect nondiabetic breast cancer women from metastasis. Clin Exp Metastasis. 2016. Epub 2016 Feb 22.
46. Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, et al. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer. 2012;118(5):1202–11. doi: 10.1002/cncr.2643921800293
47. He H, Ke R, Lin H, Ying Y, Liu D, Luo Z, Metformin, an old drug, brings a new era to cancer therapy. Cancer J. 2015;21(2):70–4. doi: 10.1097/PPO.000000000000010325815846
48. Pei XF, Noble MS, Davoli MA, Rosfjord E, Tilli MT, Furth PA, et al. Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev Biol Anim. 2004;40(1–2):14–21. 15180438